Trial intelligence / Profile preview

COCA: Glucocorticoids in Congenital Adrenal Hyperplasia

NCT02552251Phase 3Unknown

Sponsor
CHU Caen Normandie
Start
Aug 2012
Primary completion
Dec 2015
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of hydrocortisone, prednisone, dexamethasone in congenital adrenal hyperplasia (CAH), sponsored by CHU Caen Normandie. Status: unknown.

02

Drugs

hydrocortisoneprednisonedexamethasone
03

Conditions

congenital adrenal hyperplasia (CAH)

Beyond the preview

Go deeper on NCT02552251.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02552251.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call